""Costs are sky-rocketing. Breakthrough innovation is ebbing. Competition is intense and sales growth is flattening," he adds.
It all adds up to investors attributing less value to companies’ pipelines, KPMG contends.
The perception of the pharma 'value chain' needs to change to a new 'value ecosystem' "which puts the patient and the customer at its centre, with other business services wrapped around their needs", KPMG believes."
'via Blog this'
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Exemptee Institute
The Designated Representative Institute
The Health, Drug, Prescription, and GMP Supersite Gift Store
No comments:
Post a Comment